Clinical Trials Directory

Trials / Completed

CompletedNCT03459833

Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation

Glans Penis Augmentation by Hyaluronic Acid for Treatment of Premature Ejaculation: Randomized Controlled Cross-over Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Male
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled cross-over study aims to evaluate the effect and safety of glans penis augmentation using Hyaluronic acid in the treatment of premature ejaculation in compare with placebo .

Conditions

Interventions

TypeNameDescription
DRUGHyaluronic AcidGlans penis augmentation using multiple puncture technique as described by Abdallah et al. (2012) with minor modifications. HA is injected at two circular levels: one at the level of corona of glans penis and a second circular level is mid-way between the corona and urethral meatus. Six injections are injected at coronal level and four are injected in the second level, each injection is of 0.2 ml and is injected into deep dermis.

Timeline

Start date
2016-08-19
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2018-03-09
Last updated
2018-03-13

Source: ClinicalTrials.gov record NCT03459833. Inclusion in this directory is not an endorsement.